Medical Services

Thrombotic Microangiopathy (TMA) refers to a group of serious disorders characterized by the formation of small blood clots within tiny blood vessels throughout the body. These clots restrict blood flow, causing damage to organs such as the kidneys, brain, and heart. TMAs are typically associated with hemolytic anemia, low platelet counts (thrombocytopenia), and organ dysfunction.

Common causes of TMA include conditions like Thrombotic Thrombocytopenic Purpura (TTP), Hemolytic Uremic Syndrome (HUS), certain infections, autoimmune diseases, medications, and malignant hypertension. The underlying mechanism involves injury to the inner lining of blood vessels (endothelium), which triggers abnormal clot formation.

Symptoms vary based on the organs affected but often include fatigue, confusion, shortness of breath, reduced urine output, and swelling. Diagnosis is made through blood tests showing anemia and fragmented red cells, along with kidney function evaluation.

Treatment depends on the underlying cause and may include plasma exchange, immunosuppressive therapy, or targeted drugs like eculizumab. Supportive care, including dialysis and blood transfusions, may be needed in severe cases.

Early diagnosis and prompt treatment are crucial to prevent irreversible organ damage and improve patient outcomes in Thrombotic Microangiopathy.